By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tocagen Inc. 

3030 Bunker Hill Street
Suite 230
San Diego  California  92109  U.S.A.
Phone: 858-412-8400 Fax: 858-412-8499


SEARCH JOBS








Company News
FDA Grants Fast Track Designation To Tocagen Inc.'s Toca 511 & Toca FC For Treatment Of Recurrent High Grade Glioma 7/9/2015 9:58:19 AM
Tocagen Inc. Appoints Asha Das, M.D., As Vice President Of Clinical Development 6/17/2015 7:58:07 AM
Tocagen Inc. Appoints David R. Parkinson, M.D., To The Board Of Directors 5/5/2015 6:30:36 AM
Tocagen Inc. Presents Updated Interim Survival Data From Ongoing Clinical Studies At American Association Of Neurological Surgeons (AANS)/Congress Of Neurological Surgeons (CNS) Section On Tumors 5/4/2015 6:30:14 AM
Tocagen Inc. To Present Updated Interim Results From Studies Evaluating Toca 511 & Toca FC At The American Association Of Neurological Surgeons (AANS)/Congress Of Neurological Surgeons (CNS) Section On Tumors 4/30/2015 11:53:38 AM
Tocagen Inc. Appoints Paul Schimmel, Ph.D., To The Board Of Directors 2/25/2015 7:28:09 AM
Tocagen Inc. Appoints Franklin M. Berger, CFA, To The Board Of Directors 12/2/2014 12:39:40 PM
Interim Data Show Increased Median Overall Survival Of Recurrent Brain Cancer Patients Treated With Tocagen Inc.'s Toca 511 & Toca FC, Compared To Published Benchmarks 11/18/2014 1:25:58 PM
Tocagen Inc. Appoints Faheem Hasnain As Chairman Of The Board Of Directors 11/14/2014 8:25:30 AM
Tocagen Inc. To Present Toca 511 Data At The 19th Annual Scientific Meeting And Education Day Of The Society For Neuro-Oncology 11/11/2014 8:32:15 AM
12
//-->